CD4 and neoplasm: As shown in Figure 5G–J, high salt treated CD4+T cells obtained from all three sources (DLNs, tumor-splenocytes and non-tumor splenocytes) demonstrated significant anti-tumor efficiency compared with the respective mannitol treated CD4+T cells.